Abstract: This disclosure relates to glycoengineering, and methods of utilizing glycoengineering for treating various diseases or disorders (e.g., IgE-mediated disorders). The methods include administering to the subject an effective amount of a composition comprising a fusion protein described herein. In some embodiments, the IgE-mediated disorder is an allergic disorder. In some embodiments, the allergic disorder is an anaphylactic allergy.

Abstract: A clamp device clamps together two panels having aligned receiving holes, and includes a tubular wall adapted to be inserted into the aligned receiving holes and having a through hole, first and second abutment plates connected hingedly and oppositely to the tubular wall within the through hole, first and second clamping plates projecting transversely and respectively from the first and second abutment plates, two resilient arms projecting from the second abutment plate and respectively having engaging ends, and a locker having two groove sidewalls formed on the first abutment plate and confining a groove therebetween. The clamping plates move away from each other to a clamping position when the abutment plates abut against the tubular wall. The groove receives and locks the engaging ends when the abutment plates abut against the tubular wall, thereby locking the clamping plates in the clamping position.